Skip to main content
RCKT filings

Corporate insider profile

John Militello Filing Activity

Latest reported as See Remarks of ROCKET PHARMACEUTICALS, INC. (RCKT).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,240.51
Latest transaction
May 19, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 19, 2026ROCKET PHARMACEUTICALS, INC. (RCKT)See RemarksSale384$3.01$1,157
May 13, 2026ROCKET PHARMACEUTICALS, INC. (RCKT)See RemarksSale855$3.61$3,083